Recent key kidney health studies in one place: Explore a special edition of ISN TrialWatch
Can lower-exposure tacrolimus plus everolimus improve outcomes in older kidney transplant recipients? Could high-dose omega-3 supplementation offer a simple way to reduce cardiovascular risk in dialysis? Might a more conservative dialysis strategy actually help support kidney recovery?
Available in English and Russian, the ISN TrialWatch Special Edition offers a curated look at selected randomized kidney care trials from 2025 and early 2026.
Explore the special edition of TrialWatch
Each featured trial is reviewed in context and includes a risk-of-bias assessment, making it a useful resource for readers who want both the headline findings and a clearer sense of what they might mean for practice.
Find out more about the ISN research initiative behind the TrialWatch series
